ImmuVen
company
About
ImmuVen develops drugs to treat infectious diseases, cancer, and autoimmune disorders.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1.68M
- Industries
- Biotechnology,Life Science,Pharmaceutical
- Founded date
- Jan 1, 2007
- Number Of Employee
- 1 - 10
- Operating Status
- Active
ImmuVenis is a biotechnology company with novel technology to discover and develop new biotherapeutics to treat infectious disease, cancer and autoimmune disorders
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$1.68M
ImmuVen has raised a total of
$1.68M
in funding over 2 rounds. Their latest funding was raised on
May 1, 2012 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 1, 2012 | Grant | $1.68M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
ImmuVen is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
